Filters: press-releases




20160128 EGA Regulatory and Scientific Affairs Conferenc

Value Added Medicines: Rethink, Reinvent & Optimise Medicines, Improving Patient Health & Access / 31 May 2016 17:30 – 19:30, European Parliament

4 May 2016


10 Years of Biosimilar Medicines: Transforming Healthcare

28 April 2016

Biosimilar medicines provide an opportunity to increase patient access to […]

Read more

The European Parliament Calls on the Commission to Boost Manufacturing and Export of EU Generic and Biosimilar Medicines

21 April 2016

Launched on 28 October 2015 , the European Commission’s new […]

Read more

6 out of 10 Doctors Have Already Prescribed Biosimilar Medicines, According to EuropaBio Paper

20 April 2016

Medicines for Europe and its Biosimilar Medicines Group took note […]

Read more

Medicines for Europe Reinforces its Commitment to Promote Universal Access to Health

19 April 2016

Over 100 participants will explore different ways and opportunities to […]

Read more

100% increase in Patient Access to Biologic Treatments thanks to Biosimilar Medicines

30 March 2016

Biosimilar medicines represent an essential opportunity to optimise patient access to […]

Read more

EGA becomes Medicines for Europe

10 March 2016

The European Generic and Biosimilar Medicines Association is now Medicines […]

Read more

IGBA calls for full transparency and new timelines for impact assessment with regard to the voluntary WHO biological qualifier (BQ) proposal

2 March 2016


The European Biosimilars Group Appoints New Leadership Team With Sandoz’ Carol Lynch and Polpharma’s Klaus Martin

10 February 2016

Last week in Brussels, the European Biosimilar medicines Group (EBG […]

Read more

EGA Welcomes the Delegated Regulation as a Tool To Fight Counterfait Medicines

9 February 2016

Brussels – The European Generic and Biosimilar Medicines Association (EGA) welcomes […]

Read more

Subscribe to our newsletter